Shopping Cart 0
Cart Subtotal
USD 0

Oncternal Therapeutics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Oncternal Therapeutics Inc (Oncternal) is a clinical-stage oncology company that develops therapies for rare and common cancers. The company's pipeline compounds include cirmtuzumab and TK216. Its compounds are primarily focused on exciting targets which are uniquely expressed within cancer cells. Oncternal addresses different medical challenges from antibodies and antibody-drug conjugates to small molecules and chimeric antigen receptor T-cells. The company develops clinical-stage products with common regulatory and development strategies. It has academic collaborations to identify and develop novel research approaches. Oncternal is headquartered in San Diego, California, the US.

Oncternal Therapeutics Inc-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Oncternal Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Oncternal Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Oncternal Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Oncternal Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Oncternal Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Oncternal Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 10

Venture Financing 10

Oncternal Therapeutics Raises Additional USD6.6 Million in Venture Financing 10

Oncternal Therapeutics Raises USD18.4 Million in Series B Financing 11

Oncternal Therapeutics Raises Additional USD5.2 Million in Venture Financing 12

Oncternal Therapeutics Raises Additional USD2.4 Million in Venture Financing 13

Oncternal Therapeutics Raises USD0.2 Million in Venture Financing 14

Oncternal Therapeutics Raises USD13 Million in Venture Financing 15

Oncternal Therapeutics Raises Additional USD0.6 Million in Venture Financing 16

Oncternal Therapeutics Raises USD3.2 Million in Venture Financing 17

Tokalas Raises USD3.2 Million in Venture Financing 18

Tokalas Raises USD3.1 Million in Venture Financing 19

Partnerships 20

Oncternal Therapeutics Enters into Agreement with Pharmacyclics 20

Merger 21

Oncternal Therapeutics Merges with Tokalas 21

Licensing Agreements 22

Oncternal Therapeutics Enters into Licensing Agreement with University of California 22

Oncternal Therapeutics Inc-Key Competitors 23

Oncternal Therapeutics Inc-Key Employees 24

Oncternal Therapeutics Inc-Locations And Subsidiaries 25

Head Office 25

Recent Developments 26

Corporate Communications 26

Apr 03, 2018: Oncternal Therapeutics Further Strengthens Leadership with Additions to Board of Directors 26

Appendix 27

Methodology 27

About GlobalData 27

Contact Us 27

Disclaimer 27


List Of Figure

List of Figures

Oncternal Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Oncternal Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Oncternal Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Oncternal Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Oncternal Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Oncternal Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Oncternal Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Oncternal Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8


List Of Table

List of Tables

Oncternal Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts 2

Oncternal Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Oncternal Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Oncternal Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Oncternal Therapeutics Inc, Deals By Therapy Area, 2012 to YTD 2018 8

Oncternal Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Oncternal Therapeutics Raises Additional USD6.6 Million in Venture Financing 10

Oncternal Therapeutics Raises USD18.4 Million in Series B Financing 11

Oncternal Therapeutics Raises Additional USD5.2 Million in Venture Financing 12

Oncternal Therapeutics Raises Additional USD2.4 Million in Venture Financing 13

Oncternal Therapeutics Raises USD0.2 Million in Venture Financing 14

Oncternal Therapeutics Raises USD13 Million in Venture Financing 15

Oncternal Therapeutics Raises Additional USD0.6 Million in Venture Financing 16

Oncternal Therapeutics Raises USD3.2 Million in Venture Financing 17

Tokalas Raises USD3.2 Million in Venture Financing 18

Tokalas Raises USD3.1 Million in Venture Financing 19

Oncternal Therapeutics Enters into Agreement with Pharmacyclics 20

Oncternal Therapeutics Merges with Tokalas 21

Oncternal Therapeutics Enters into Licensing Agreement with University of California 22

Oncternal Therapeutics Inc, Key Competitors 23

Oncternal Therapeutics Inc, Key Employees 24

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Oncternal Therapeutics Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.